Company / Capital Returned to Shareholders per Share
Exelixis Capital Returned to Shareholders per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$3.36
FY2025
5-year range
$1.70 / $3.36
FY2023-FY2025
Trend
+56.2%
vs FY2024
Sector context
#9 of 51
Health Care
What the data says
Exelixis's capital returned to shareholders per share of $3.36 is higher than 82% of companies in the Health Care sector (FY2025). Improved from $1.70 to $3.36 over the past 2 years.
Based on SEC 10-K filings.
3.36 in FY2025. Top quartile in the Health Care sector.
Improved from $1.70 to $3.36 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 51This company $3.36 Sector average $2.74
▼
+23.0% above sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share increased 56.2% year-over-year.
- Ranks #9 out of 51 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.36 | +56.2% |
| FY2024 | $2.15 | +26.7% |
| FY2023 | $1.70 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026